Patents by Inventor ÉTIENNE GAGNON

ÉTIENNE GAGNON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230272068
    Abstract: The present application relates to modular chimeric receptors, such as chimeric antigen receptors (CARs) comprising chimeric receptor and signaling modules with synthetic transmembrane domains that favor electrostatic interactions between the synthetic transmembrane domains in the cell membrane while eliminating or minimizing electrostatic interactions with the native transmembrane domains of immune receptors and signaling proteins. The modular chimeric receptors, which mimic the structure and signaling of native immune receptors, enable the distribution of the signaling domains across different cytoplasmic chains, display suitable surface expression as well as improved kinetics and sensitivities relative to current standard-of-care (SOC) CAR-based therapies.
    Type: Application
    Filed: August 20, 2021
    Publication date: August 31, 2023
    Inventor: Étienne GAGNON
  • Patent number: 10324085
    Abstract: Described herein is a bioluminescence resonance energy transfer (BRET) based system and method to monitor ternary complex formation in real-time in live cells with high sensitivity and accuracy. This system transfers energy simultaneously between a luciferase donor and intermediate and terminal acceptors, appropriately chosen to also enable transfer from the intermediate to terminal acceptor while minimizing contaminating signals. The system may also be adapted for quaternary complex detection by including a protein complementation assay (PCA) component. The system is broadly applicable to the detection of any protein ternary/quaternary complex such as those involving nuclear receptors, GPCRs, Receptor Tyrosine Kinase (RTKs), multimeric enzymes or structural proteins.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: June 18, 2019
    Assignee: UNIVERSITÉ DE MONTRÉAL
    Inventors: David Cotnoir-White, Sylvie Mader, Étienne Gagnon, Michel Bouvier
  • Publication number: 20170038367
    Abstract: Described herein is a bioluminescence resonance energy transfer (BRET) based system and method to monitor ternary complex formation in real-time in live cells with high sensitivity and accuracy. This system transfers energy simultaneously between a luciferase donor and intermediate and terminal acceptors, appropriately chosen to also enable transfer from the intermediate to terminal acceptor while minimizing contaminating signals. The system may also be adapted for quaternary complex detection by including a protein complementation assay (PCA) component. The system is broadly applicable to the detection of any protein ternary/quaternary complex such as those involving nuclear receptors, GPCRs, Receptor Tyrosine Kinase (RTKs), multimeric enzymes or structural proteins.
    Type: Application
    Filed: December 23, 2014
    Publication date: February 9, 2017
    Inventors: DAVID COTNOIR-WHITE, SYLVIE MADER, ÉTIENNE GAGNON, MICHEL BOUVIER
  • Patent number: D471409
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: March 11, 2003
    Assignee: Alcas Corporation
    Inventors: Peter W. Bressler, Peter D. Byar, Luc-Etienne Gagnon, Leslie A. Juhng